OMassachusetts biotech company Moderna announced on Monday that its coronavirus vaccine was 95% effective in phase three trials, just a week after rival pharmaceutical giant Pfizer announced that its own candidate was effective at least 90%.
Early trial results suggest that at least two vaccines using unprecedented technology are potentially weeks away from initial approval – and stem the tide of a pandemic infecting well over 100,000 Americans a day. But if the growing number of seemingly viable vaccines point to a way out of the pandemic, experts have warned, hundreds of thousands more Americans could die first.
welcome to Rabbit hole, where we dig deeper into the bigger story. This is reserved for members of Beast Inside. Join us today.
#Moderna #Pfizer #vaccines #gamechanger